Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
1994 • 1,695 citations
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
1993 • 1,031 citations
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
1993 • 714 citations
Humanised monoclonal antibody therapy for rheumatoid arthritis
1992 • 316 citations
Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placebo
1990 • 289 citations
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
1994 • 188 citations
Tumor necrosis factor: Molecular and cellular biology and clinical relevance
1995 • 45 citations
New Directions for Biological Therapy in Rheumatoid Arthritis
1994 • 30 citations
Does TNFa Have a Pivotal Role in the Cytokine Network in Rheumatoid Arthritis?
2015 • 3 citations